INHIBITORY EFFECT OF TUMOR NECROSIS FACTOR-α SECRETION FROM RAT ASTROCYTES BY CHILBOKEUM

REFERENCES

• Fontana A., Frei K., Bodmer S., Hofer E. Immune-mediated encephalitis; on the role of antigen-presentingcells in brain tissue. Immunol. Rev. 1987; 100: 185
   PubMed Web of Science ®Google Scholar
• Benveniste E. N. Chemical immunology: Neuroimmunoendocrinology. S.Karger, Basel 1991; 52
   Google Scholar
• Fierz W., Endler B., Reske K., Wekerle H., Fontana A. Astrocytes as antigen presenting cells. I. Induction of Ia antigenexpression on astrocytes by T cells via immune interferon and its effect onantigen presentation. J. Immunol. 1985; 134: 3785
   PubMed Web of Science ®Google Scholar
• Chung I. Y., Benveniste E. N. Tumor necrosis factor-alpha production by astrocytes: inductionby lipopolysaccharide, interferon-gamma and interleukin-1. J. Immunol. 1990; 144: 2999
   PubMed Web of Science ®Google Scholar
• Lieberman A. P., Pitha P. M., Shin H. S., Shin M. L. Production of tumor necrosis factor and other cytokines by astrocytesstimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl. Acad. Sci. U. S. A. 1989; 86: 6348
   PubMed Web of Science ®Google Scholar
• Torrens Y., Beaujouan J. C., Saffroy M., Daguet de Montety M. C., Bergstrom L., Glowinski J. Substance P receptors in primary cultures of cortical astrocytesfrom the mouse. Proc. Natl. Acad. Sci. U. S. A. 1986; 86: 9216
   Google Scholar
• Luber-Narod J., Kage R., Leeman S. E. Substance P enhances the secretion of tumor necrosis factor-αfrom neuroglial cells stimulated with lipopolysaccharide. J. Immunol. 1994; 152: 819
   PubMed Web of Science ®Google Scholar
• Beutler B., Cerami A. The biology of cachectin/TNF-α primary mediator of thehost response. Annu. Rev. Immunol. 1998; 7: 625
   Google Scholar
• Robbins D. S., Shirazi Y., Drysdale B. E., Lieberman A., Shin H. S., Shin M. L. Production of cytotoxic factor for oligodendrocytes by stimulatedastrocytes. J. Immunol. 1987; 139: 2593
   PubMed Web of Science ®Google Scholar
• Bethea J. R., Gillespie G. Y., Chung I. Y., Benveniste E. N. Tumor necrosis factor reduction and receptor expression by ahuman malignant glioma cell line, D54-MG. J. Neuroimmunol. 1990; 30: 1
   PubMed Web of Science ®Google Scholar
• Benveniste E. N., Sparacio S. M., Bethea J. R. Tumor necrosis factor-alpha enhances nterferon-gamma-mediatedclass II antigen expression on astrocytes. J. Neuroimmunol. 1989; 25: 209
   PubMed Web of Science ®Google Scholar
• Kim H. M., Lee E. H., Shin T. K., Chung C. K., An N. H. Inhibition of the induction of the inducible nitric oxide synthasein murine brain microglial cells by sodium salicylate. Immunology 1998; 95: 389
   PubMed Web of Science ®Google Scholar
• Kim H. M., Lee E. H., Lim T. K., Jung J. A., Lyu Y. S. Inhibitory effect of Asparagus cochinchinensis on tumor necrosisfactor-alpha secretion from astrocytes. Int. J. Immunopharmacol. 1998; 20: 153
   PubMed Web of Science ®Google Scholar
• Hassan N. F., Rifat S., Campbell D. E., McCawley L. J., Douglas S. D. Isolation and flow cytometric characterization of new born mousebrain-derived microglia maintained in vitro. J. Leukoc. Biol. 1991; 50: 86
   PubMed Web of Science ®Google Scholar
• Kim H. M., Lee Y. M. Role of TGF-β1 on the IgE-dependent anaphyolaxis reaction. J. Immunol. 1999; 162: 4960
   PubMed Web of Science ®Google Scholar
• Kim H. M., Lee Y. J., Lyu Y. S. Inhibition of lipopolysaccharide plus substance P-induced tumornecrosis factor-α production from astrocytes by Chongmyung-Tang. J. Ethnopharmacol. 1999; 66: 295
   PubMed Web of Science ®Google Scholar
• Kim H. M., An C. S., Jung K. Y., Choo Y. K., Park J. K., Nam S. Y. Rehmannia glutinosa inhibits tumour necrosis factor-alpha andinterleukin-1 secretion from mouse astrocytes. Pharmacol. Res. 1999; 40: 171
   PubMed Web of Science ®Google Scholar
• Fontana A., Kristensen F., Dubs R., Gemsa D., Weber E. Production of prostaglandin E and an interleukin-1-like factorby cultured astrocytes and C6 glioma cells. J. Immunol. 1982; 129: 2413
   PubMed Web of Science ®Google Scholar
• Hofman F. M., Hinton D. R., Johnson K., Merrill J. E. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 1989; 170: 607
   PubMed Web of Science ®Google Scholar
• Kim H. M. Antiallergy drugs from Oriental medicines. Int. J. Orient. Med. 2000; 1: 1
   Google Scholar
• Selmaj K., Raine C. S., Cannella B., Brosnan C. F. Identification of lymphotoxin and tumor necrosis factor in multiplesclerosis lesions. J. Clin. Invest. 1991; 87: 949
   PubMed Web of Science ®Google Scholar
• Fillit H., Ding W. H., Buce L., Kalman J., Altstiel L., Lawlor B., Wolf-klein G. Elevated circulating tumor necrosis factor levels in Alzheimer'sdisease. Neurosci. Lett. 1991; 129: 318
   PubMed Web of Science ®Google Scholar
• Griffin W. S., Stanley L. C., Lung C., White L., MacLeod V., Perott J., White C. L., Araoz C. Brain interleukin-1 and s-100 immunoreactivity are elevatedin Down syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 1989; 86: 7611
   PubMed Web of Science ®Google Scholar
• Rogers J., Luber-Narod J. Immune actions in the nervous system: a brief review with specialemphasis on Alzheimer's Disease. Drug Dev. Res. 1988; 15: 227
   Web of Science ®Google Scholar
• Forloni G., Demicheli F., Giorgi S., Bendotti C., Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial,neuronal, and glial cells: modulation by interleukin-1. Brain Res. Mol. Brain Res. 1992; 16: 128
   PubMedGoogle Scholar
• Perrella O., Carrieri P. B., Guarnaccia D., Soscia M. Cerebrospinal fluid cytokines in AIDS mementia complex. J. Neurol. 1992; 239: 387
   PubMed Web of Science ®Google Scholar